Skip to main content

Pantothenate Kinase-Associated Neurodegeneration clinical trials at UC Irvine
1 in progress, 0 open to eligible people

  • Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients

    Sorry, in progress, not accepting new patients

    This study will investigate whether fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy, is safe and effective in treating patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN).

    Irvine, California and other locations

Last updated: